CN112111461B - 一种单细胞分选构建单克隆抗体高产株细胞工作库的方法 - Google Patents
一种单细胞分选构建单克隆抗体高产株细胞工作库的方法 Download PDFInfo
- Publication number
- CN112111461B CN112111461B CN202010824126.6A CN202010824126A CN112111461B CN 112111461 B CN112111461 B CN 112111461B CN 202010824126 A CN202010824126 A CN 202010824126A CN 112111461 B CN112111461 B CN 112111461B
- Authority
- CN
- China
- Prior art keywords
- cells
- cell
- culture
- hybridoma
- single cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 22
- 210000004027 cell Anatomy 0.000 claims abstract description 141
- 210000004408 hybridoma Anatomy 0.000 claims abstract description 47
- 230000032683 aging Effects 0.000 claims description 6
- 230000035755 proliferation Effects 0.000 claims description 4
- 230000002401 inhibitory effect Effects 0.000 claims description 3
- 230000004936 stimulating effect Effects 0.000 claims description 3
- 230000000638 stimulation Effects 0.000 abstract description 13
- 238000004113 cell culture Methods 0.000 abstract description 11
- 210000003719 b-lymphocyte Anatomy 0.000 abstract description 7
- 230000028327 secretion Effects 0.000 abstract description 4
- 239000001963 growth medium Substances 0.000 description 25
- 239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 20
- 239000006228 supernatant Substances 0.000 description 20
- 230000003187 abdominal effect Effects 0.000 description 16
- 239000012091 fetal bovine serum Substances 0.000 description 16
- 210000002540 macrophage Anatomy 0.000 description 16
- 239000000243 solution Substances 0.000 description 16
- 241000699666 Mus <mouse, genus> Species 0.000 description 12
- 238000010790 dilution Methods 0.000 description 12
- 239000012895 dilution Substances 0.000 description 12
- 238000012258 culturing Methods 0.000 description 10
- 230000003321 amplification Effects 0.000 description 8
- 230000010261 cell growth Effects 0.000 description 8
- 230000002354 daily effect Effects 0.000 description 8
- 238000003199 nucleic acid amplification method Methods 0.000 description 8
- 210000004303 peritoneum Anatomy 0.000 description 8
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 7
- 238000001514 detection method Methods 0.000 description 6
- 238000007865 diluting Methods 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 210000000683 abdominal cavity Anatomy 0.000 description 4
- 230000006978 adaptation Effects 0.000 description 4
- 238000011091 antibody purification Methods 0.000 description 4
- 238000010009 beating Methods 0.000 description 4
- 238000007664 blowing Methods 0.000 description 4
- 238000010276 construction Methods 0.000 description 4
- 239000012228 culture supernatant Substances 0.000 description 4
- 239000012894 fetal calf serum Substances 0.000 description 4
- 230000002147 killing effect Effects 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000013642 negative control Substances 0.000 description 4
- 239000008188 pellet Substances 0.000 description 4
- 210000003024 peritoneal macrophage Anatomy 0.000 description 4
- 238000002791 soaking Methods 0.000 description 4
- 230000016784 immunoglobulin production Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 206010035226 Plasma cell myeloma Diseases 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 201000000050 myeloid neoplasm Diseases 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 239000012679 serum free medium Substances 0.000 description 2
- 238000001042 affinity chromatography Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000012516 mab select resin Substances 0.000 description 1
- 238000013411 master cell bank Methods 0.000 description 1
- 210000004180 plasmocyte Anatomy 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C12N5/12—Fused cells, e.g. hybridomas
- C12N5/16—Animal cells
- C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2809—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2812—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD4
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B50/00—Methods of creating libraries, e.g. combinatorial synthesis
- C40B50/06—Biochemical methods, e.g. using enzymes or whole viable microorganisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2304—Interleukin-4 (IL-4)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/50—Cell markers; Cell surface determinants
- C12N2501/599—Cell markers; Cell surface determinants with CD designations not provided for elsewhere
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010824126.6A CN112111461B (zh) | 2020-08-17 | 2020-08-17 | 一种单细胞分选构建单克隆抗体高产株细胞工作库的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010824126.6A CN112111461B (zh) | 2020-08-17 | 2020-08-17 | 一种单细胞分选构建单克隆抗体高产株细胞工作库的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112111461A CN112111461A (zh) | 2020-12-22 |
CN112111461B true CN112111461B (zh) | 2022-08-30 |
Family
ID=73803771
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010824126.6A Active CN112111461B (zh) | 2020-08-17 | 2020-08-17 | 一种单细胞分选构建单克隆抗体高产株细胞工作库的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112111461B (zh) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2818892A1 (en) * | 2010-11-24 | 2012-05-31 | Duke University | Adjuvant |
CN103421113B (zh) * | 2012-05-22 | 2018-01-19 | 武汉华鑫康源生物医药有限公司 | 抗BLyS抗体 |
CN103898060B (zh) * | 2012-12-25 | 2015-12-23 | 深圳先进技术研究院 | Hat半固体筛选培养基以及杂交瘤细胞的筛选方法 |
-
2020
- 2020-08-17 CN CN202010824126.6A patent/CN112111461B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN112111461A (zh) | 2020-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU670316B2 (en) | An improved method of (agrobacterium)-mediated transformation of cultured soybean cells | |
Vasil et al. | Totipotency and embryogenesis in plant cell and tissue cultures | |
EP1687414B1 (en) | Method of isolating and culturing mesenchymal stem cell derived from umbilical cord blood | |
Gosch et al. | Isolation, culture, and induction of embryogenesis in protoplasts from cell-suspensions of Atropa belladonna | |
JP2012508562A5 (zh) | ||
CN112680415A (zh) | 一种nk培养基及其扩增培养方法 | |
CN114921416B (zh) | 一种nk细胞及其制备方法 | |
CN108085337A (zh) | 一种gs表达系统细胞株的筛选方法 | |
CN112111461B (zh) | 一种单细胞分选构建单克隆抗体高产株细胞工作库的方法 | |
CN113564117B (zh) | 一种冻存脐带血来源调节性t细胞体外扩增优化方法 | |
CN112080469B (zh) | T1肽在体外促进脐带血造血干细胞增殖中的应用 | |
JP7025524B2 (ja) | 非動員末梢血を利用した不均一性造血幹細胞・前駆細胞の製造方法 | |
CN104894054A (zh) | 一种猴胚胎肾上皮细胞Marc-145悬浮适应株及其在培养蓝耳病病毒、生产蓝耳病毒疫苗中的应用 | |
CN107922924A (zh) | Cd34+cd41暗巨核细胞祖细胞及其用于产生带有前血小板的mk和/或血小板的应用 | |
CN116376822A (zh) | 利用人多潜能干细胞体外制备t淋巴细胞 | |
US4721675A (en) | Production of hepatitis A virus in vitro utilizing a persistently virus infected cell culture system | |
Louzada et al. | Preparation and fusion of Citrus sp. microprotoplasts | |
CN108239620A (zh) | IFN-β1编码基因缺失的MDCK细胞株及其构建方法和应用 | |
Gosch et al. | Isolation, culture, and fusion studies on protoplasts from different species | |
Brahe et al. | A simple method for fusing human lymphocytes with rodent cells in monolayer by polyethylene glycol | |
CN114149977A (zh) | 一种小鼠肺微血管内皮细胞永生化以获得胞外囊泡的方法 | |
CN110396496B (zh) | 一种鸭小肠上皮细胞的培养方法及应用 | |
AU2020102372A4 (en) | Bhk21 cell population with reconstructed innate immune system, and use of cell clones thereof in virus proliferation | |
Huang et al. | Tissue culture investigations of bamboo V, Recovery of callus from protoplasts of suspension-cultured | |
KR102648479B1 (ko) | 단백질 기반 의약들 (protein-based pharmaceuticals) 의 고 수준 생산을 위한 세포주들 (cell lines) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: Building 1 and 3, No. 926, Changhong East Street, Fuxi Street, Huzhou, Zhejiang Province, 313000 (Mount Mogan National High tech Zone) Patentee after: Zhejiang Zhengxi Biotechnology Co.,Ltd. Address before: Building 1, No. 926, Changhong East Street, Fuxi street, Deqing County, Huzhou City, Zhejiang Province, 313000 (Moganshan national high tech Zone) Patentee before: ZHEJIANG ZHENGXI BIOMEDICAL Co.,Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A method for constructing a high-yield monoclonal antibody cell library through single-cell sorting Granted publication date: 20220830 Pledgee: Deqing sub branch of Bank of China Ltd. Pledgor: Zhejiang Zhengxi Biotechnology Co.,Ltd. Registration number: Y2024980010535 |